期刊文献+

胃癌患者血清及组织中组织蛋白酶-D、谷胱甘肽-S-转移酶活性测定的临床意义 被引量:1

Cath-D and GST Activities in the Serum and Tissue of Patients with Gastric Carcinoma
下载PDF
导出
摘要 目的 探讨组织蛋白酶 - D(Cath- D)、谷胱甘肽 - S-转移酶 (GST)活性变化与胃癌发生、发展及预后的关系。 方法 检测胃癌、单纯性胃炎、胃炎伴癌前病变患者血清、癌组织、癌旁组织、胃窦粘膜中 Cath- D、GST的活性和手术前后血清 GST活性。 结果  (1)胃癌组的 Cath- D、GST的活性显著高于单纯性胃炎组及胃炎伴癌前病变组 (P<0 .0 1) ,胃炎伴癌前病变组 GST的活性显著高于单纯性胃炎组 (P<0 .0 5 ) ,Cath- D活性与单纯性胃炎组比较差异无显著性 (P>0 .0 5 )。 (2 )胃癌组织 Cath- D、GST的活性显著高于癌旁组织 (P<0 .0 5 )、癌旁组织中Cath- D、GST的活性显著高于对照组织 (P<0 .0 5 )。 (3)伴有淋巴结转移的胃癌组织中 Cath- D活性显著高于不伴有淋巴结转移的 (P<0 .0 5 ) ,GST的活性在伴有与不伴有淋巴结转移者中差异无显著性 (P>0 .0 5 )。 (4) Cath- D的活性与按预后好坏的组织学分型 (P<0 .0 1)、按 TNM的分期 (P<0 .0 1)等病理指标有密切相关 ,而 GST的活性与病理指标无显著相关 (P>0 .0 5 )。 (5 )胃癌手术后 10天血清中 GST的活性明显低于手术前 (P<0 .0 1)。 结论 Cath- D、GST活性联合检测可用于胃癌高危人群筛选。 Objective\ To study the relationship between activity change of Cath\|D and GST and the incidence,development, prognosis of gastric carcinoma.\ Methods\ The activity of Cath\|D and GST in serum,carcinoma tissue, paracarcinoma tissue, normal antral gastric tissue were assayed in gastric carcinoma and chronic simple gastritis and chronic gastritis complicated with precarcinous lesion.\ The activities of GST in serum of gastric carcinoma were also compared before\|and after operations.\ Results\ (1)The activit...
出处 《福建医科大学学报》 2001年第S1期32-35,共4页 Journal of Fujian Medical University
基金 福建省教委 B类基金资助项目 ( 98B0 0 3)
关键词 组织蛋白酶D 谷胱甘肽转移酶类 胃肿瘤 cathepsin\|D glutathione s\|transferase gastric carcinoma
  • 相关文献

参考文献5

二级参考文献3

共引文献21

同被引文献17

  • 1胡敏,王海江.P21ras、VEGF、Survivin在胃癌组织中的表达及意义[J].新疆医科大学学报,2006,29(6):492-495. 被引量:3
  • 2邓联球,王万川,廖国庆.大肠癌患者血清及组织中组织蛋白酶-D活性测定的临床意义[J].中国普通外科杂志,2006,15(10):809-811. 被引量:5
  • 3Dvalishvili I, Charkviani L, Charkviani T, et al. Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarci- noma [ J ]. Georgian Med News,2005,12 (6) :27-31.
  • 4Leto G, TummineUo FM, Crescimanno M, et al. Cathepsin D ex- pression levels in nongynecological solid tumors:clinical and ther- apeutic implications [ J ]. Clin Exp Metastasis, 2004,21 ( 2 ) : 91 -106.
  • 5Yan Y, Ai Z, Wang J, et al. Influence of epidermal growth factor receptor inhibitor AG1 478 on epithelial-mesenchymal transition in endometrial carcinoma cells[J]. Int J Gynecol Cancer,2012, 22(9) :1457-1462.
  • 6Jedryka M, Chrobak A, Chelmonska-Soyta A, et al. Matrix metal- loproteinase (MMP)-2 and MMP-9 expression in tumor infiltra- ting CD3 lymphocytes from women with endometrial cancer [ J ]. Int J Gynecol Cancer,2012,22(8) :1303-1309.
  • 7Mylonas I, Makovitzky J, Richter DU, et al. Cathepsin D expres- sion in normal, hyperplastic and malignant endometrial tissue:an analysis [ J]. Acta Histochem, 2003, 105 (3) :245-252.
  • 8Bradley WH, Lima PH, Rodgers L, et al. Endometrial carcinoma expresses an increased cathepsin B/D ratio [ J ]. Gynecol Oncol, 2008,108 ( 1 ) : 84-89.
  • 9Puljiz M, Puljiz Z, Vucemilo T, et al. Prognostic significance of matrix metalloproteinases 2 and 9 in? endometrial cancer [ J ]. Coil Antropol,2012,36(4) :1367-1372.
  • 10Yu F,Jiang Q,Zhou Y,et al. Abnormal expression of matrix met- alloproteinase-9 (MMIx)) correlates with clinical course in Chi- nese patients with endometrial cancer[ J ]. Dis Markers, 2012,32 (5) :321-327.

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部